ERBB2 and breast cancer: Triple negative breast cancer (TNBC) accounts for 15–20% of all breast cancers and refers to tumours which have <1% expression of both estrogen (ER) and progesterone receptors (PR) and do not over express human epidermal growth factor receptor 2 (HER2) [1, 2].